Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, Observational, and Non-Randomized Open Label Interventional Study

Avner Ehrlich, Konstantinos Ioannidis, Makram Nasar, Ismaeel Abu Alkian, Yuval Daskal, Nofar Atari, Limor Kliker, Nir Rainy, Matan Hofree, Sigal Shafran Tikva, Inbal Houri, Arrigo Cicero, Chiara Pavanello, Cesare R. Sirtori, Jordana B. Cohen, Julio A. Chirinos, Lisa Deutsch, Merav Cohen, Amichai Gottlieb, Adina Bar-ChaimOren Shibolet, Michal Mandelboim, Shlomo L. Maayan, Yaakov Nahmias*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, Observational, and Non-Randomized Open Label Interventional Study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds